Please login to the form below

Not currently logged in
Email:
Password:

Giotrif

This page shows the latest Giotrif news and features for those working in and with pharma, biotech and healthcare.

Pfizer gets EU nod for Tagrisso rival Vizimpro

Pfizer gets EU nod for Tagrisso rival Vizimpro

Tarceva (erlotinib) and Boehringer Ingelheim’s second-generation Giotrif (afatinib) in the market.

Latest news

More from news
Approximately 7 fully matching, plus 36 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics